Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (618)	2/4/2002 11:28:46 PM
From: Jibacoa	Respond to of 1005

Sorry for the wrong link.<g> The correct link for the latest insider's trades on ITMN is: biz.yahoo.com If the items are correct, Dr. Engelman sold stock in November & December for $16,259,800 and still has a Proposed Sale (Form 144)for another 58,750 shares. Bernard

To: Jibacoa who wrote (618)	2/5/2002 12:03:21 AM
From: tuck	Read Replies (1) \| Respond to of 1005

Bernard, I am pretty confident that BLUE HP will make money on that trade sooner or later. ITMN is one of the best managed biotechs out there, methinks. Good dealmakers with good taste. And that was a nibble. BLUE HP still has some cash. It has made some clinical and business progress since the worst lows, too. If I am wrong about the short term direction, I will likely re-allocate some of my own funds to buy in the low 30s/high 20s. And sleep well. Have you got any recommendations as to BLUE HPs cash stash? Or are you gunshy about everything for the moment? BTW, I will most definitely take short suggestions, or sell recommendations. Wondering for instance, about CIPH, and the litigation simmering there. Ditto AMEV, though I would guess that is farther in the future. Cheers, Tuck